| 0 |
MINIMUM INHIBITORY CONCENTRATION INCREASED |
2 |
0.1000 |
| 1 |
PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER |
1 |
0.0096 |
| 2 |
PANCREATIC ABSCESS |
1 |
0.0050 |
| 3 |
INFUSION SITE PHLEBITIS |
1 |
0.0044 |
| 4 |
VASCULAR ACCESS SITE COMPLICATION |
1 |
0.0040 |
| 5 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
1 |
0.0035 |
| 6 |
CREATININE RENAL CLEARANCE INCREASED |
2 |
0.0027 |
| 7 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0021 |
| 8 |
ABDOMINAL WALL ABSCESS |
1 |
0.0015 |
| 9 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 10 |
ALLERGIC COUGH |
1 |
0.0013 |
| 11 |
BLOOD CULTURE POSITIVE |
2 |
0.0007 |
| 12 |
MEDICAL DEVICE PAIN |
1 |
0.0005 |
| 13 |
BRAIN ABSCESS |
1 |
0.0004 |
| 14 |
EXTRAVASATION |
1 |
0.0002 |
| 15 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 16 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 17 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 18 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 19 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 20 |
DRUG DIVERSION |
1 |
0.0002 |
| 21 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 22 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 23 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 24 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0001 |
| 25 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 26 |
DRUG ERUPTION |
2 |
0.0001 |
| 27 |
FLANK PAIN |
1 |
0.0001 |
| 28 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 29 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 30 |
DRUG RESISTANCE |
2 |
0.0001 |
| 31 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 32 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 33 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 34 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 35 |
HEPATOTOXICITY |
1 |
0.0000 |
| 36 |
INFLAMMATION |
2 |
0.0000 |
| 37 |
RASH PRURITIC |
2 |
0.0000 |
| 38 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 39 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 40 |
HYPOXIA |
1 |
0.0000 |
| 41 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 42 |
OFF LABEL USE |
19 |
0.0000 |
| 43 |
SWELLING |
2 |
0.0000 |
| 44 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 45 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 46 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 47 |
SEIZURE |
2 |
0.0000 |
| 48 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 49 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 50 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 51 |
ERYTHEMA |
3 |
0.0000 |
| 52 |
BURNING SENSATION |
1 |
0.0000 |
| 53 |
MOBILITY DECREASED |
1 |
0.0000 |
| 54 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 55 |
EPISTAXIS |
1 |
0.0000 |
| 56 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 57 |
TREATMENT FAILURE |
1 |
0.0000 |
| 58 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 59 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 60 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 61 |
RASH |
3 |
0.0000 |
| 62 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 63 |
HYPOAESTHESIA |
1 |
0.0000 |
| 64 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 65 |
PARAESTHESIA |
1 |
0.0000 |
| 66 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 67 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 68 |
DEATH |
5 |
0.0000 |
| 69 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 70 |
PRURITUS |
2 |
0.0000 |
| 71 |
HYPOTENSION |
1 |
0.0000 |
| 72 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 73 |
HEADACHE |
2 |
0.0000 |
| 74 |
PNEUMONIA |
1 |
0.0000 |
| 75 |
PYREXIA |
1 |
0.0000 |
| 76 |
ASTHENIA |
1 |
0.0000 |
| 77 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 78 |
DIARRHOEA |
1 |
0.0000 |